ARCHIVES

In Brief: Hew Approves Patent Request From U. Arizona; Califano Still Pondering Bioassay Program Fate

This article is from The Cancer Letter archive.

Vol. 04 No. 35 | September 1, 1978

Download PDF Visit The Full Archive

Related Articles

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

Includes Sept. Business & Regulatory Report.

September 26, 2003

New Organ Systems Concept Flow Discussed

October 18, 1985

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997